gdc

November 2020 – Lung Cancer

Lung Cancer Stigma Can Cause Death
Issue IntroductionsLung Cancer
In her introduction to the November 2020 issue that is focused on lung cancer, Lillie D. Shockney discusses the articles and dispels the common assumption that only smokers get lung cancer.
Just Ask Frank Sierawski: Anybody with Lungs Can Get Lung Cancer
Lung CancerPatient Stories
Frank Sierawski had never smoked and had no family or personal history of lung problems, but what started out as a distressing cough ended up being lung cancer.
Nutrition Tips for Patients with Lung Cancer: Maintaining a Healthy Body Weight
Lung CancerNutrition & Cancer
Oncology nutritionist Julie Lanford presents nutrition tips for patients with lung cancer, advocating for a health plan to combat unintentional weight loss and managing poor appetite.
Why I Fight for Lung Cancer Awareness
CaregiversLung Cancer
When her mother was diagnosed with stage IIIB lung cancer, Danielle Hicks took an active role in caring for her and found her purpose helping other patients going through the same fight.
Gavreto Second Drug FDA Approved for Patients with Metastatic Lung Cancer and RET Fusions
FDA Approvals, News & UpdatesLung Cancer
In September 2020, the FDA approved a second drug for the treatment of patients with lung cancer and RET fusions, improving the treatment options available today for patients with this type of lung cancer.
Beauty Is a Side Effect of (Lung) Cancer
Lung CancerPatient Stories
A.J. Patel, who ran around 20 miles a week as a semi-professional soccer referee, was shocked to get a lung cancer diagnosis and dismayed when his relationships strained. Then, an estranged uncle came to his aid.
A Walk on Nature’s Path
Art Therapy
Pattie Dorf created a painting of two people walking through the woods that expresses her feeling that “our life can create the choices we make with illness.”
New Therapies Improve Survival in Patients with Lung Cancer Associated with a Biomarker
BiomarkersLung Cancer
At the October 2020 conference of the European Society for Medical Oncology (ESMO), researchers presented information on new or recently approved targeted therapies and immunotherapies for lung cancer.
Retevmo First Drug FDA Approved for Patients with Metastatic Lung Cancer and RET Fusions
FDA Approvals, News & UpdatesLung Cancer
In May 2020, the FDA approved the first drug ever for the treatment of patients with lung cancer and RET fusions, a type of biomarker that can lead to lung cancer and requires specific drug therapy.
Oncogene Alterations Affect the Response to Targeted Therapies in Patients with Non–Small-Cell Lung Cancer and ALK Rearrangements
Lung Cancer
One biomarker that is involved in lung cancer is the ALK mutations. Although several drugs are now available for this type of lung cancer, new evidence shows that some patients may need different therapies.

Results 1 - 10 of 10

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country